Scynexis at a Crossroads: Can a GSK Deal Reverse Its Fortunes?
The shares of biotechnology firm Scynexis are trading deep in negative territory, yet a recent $25 million agreement with pharmaceutical ...
The shares of biotechnology firm Scynexis are trading deep in negative territory, yet a recent $25 million agreement with pharmaceutical ...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.
© 2023 StocksToday.com